Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Error occurred: cannot get document summary
Neurobiology of emotional dysfunction in schizophrenia: new directions revealed through meta-analyses.
Anticevic A, Van Snellenberg JX, Barch DM.
Biol Psychiatry. 2012 Mar 15;71(6):e23-4; author reply e25. Epub 2011 Dec 28. No abstract available.
Related citations
Great wits and madness: more near allied?
Jamison KR.
Br J Psychiatry. 2011 Nov;199(5):351-2.
Creativity and mental disorder: family study of 300,000 people with severe mental disorder.
Kyaga S, Lichtenstein P, Boman M, Hultman C, Långström N, Landén M.
Br J Psychiatry. 2011 Nov;199(5):373-9. Epub 2011 Jun 8.
Identifying attentional deficits in people with first-episode psychosis with the Scale for the Assessment of Negative Symptoms attention subscale: is it possible?
González-Blanch C, Priede A, Rodríguez-Sánchez JM, Perez-Iglesias R, Vázquez-Barquero JL, Crespo-Facorro B.
Compr Psychiatry. 2011 Dec 27. [Epub ahead of print]
Tetrabenazine augmentation in treatment-resistant schizophrenia: a 12-week, double-blind, placebo-controlled trial.
Remington G, Kapur S, Foussias G, Agid O, Mann S, Borlido C, Richards S, Javaid N.
J Clin Psychopharmacol. 2012 Feb;32(1):95-9.
Asenapine versus olanzapine in people with persistent negative symptoms of schizophrenia.
Buchanan RW, Panagides J, Zhao J, Phiri P, den Hollander W, Ha X, Kouassi A, Alphs L, Schooler N, Szegedi A, Cazorla P.
J Clin Psychopharmacol. 2012 Feb;32(1):36-45.
Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.
Miura I, Takeuchi S, Katsumi A, Mori A, Kanno K, Yang Q, Mashiko H, Numata Y, Niwa S.
J Clin Psychopharmacol. 2012 Feb;32(1):106-9.
Does the medication pattern reflect the CYP2D6 genotype in patients with diagnoses within the schizophrenic spectrum?
Jürgens G, Rasmussen HB, Werge T, Dalhoff K, Nordentoft M, Andersen SE.
J Clin Psychopharmacol. 2012 Feb;32(1):100-5.
All-cause mortality and medication risk factors in schizophrenia: a prospective cohort study.
Tenback D, Pijl B, Smeets H, Os Jv, Harten Pv.
J Clin Psychopharmacol. 2012 Feb;32(1):31-5.
Carnitine supplementation for valproate-related hyperammonemia to maintain therapeutic valproate level.
Sonik P, Hilty DM, Rossaro L, Bourgeois JA.
J Clin Psychopharmacol. 2011 Oct;31(5):680-2. No abstract available.
Hyperosmolar hyperglycemic state associated with ziprasidone treatment: a case report.
Létourneau G, Abdel-Baki A, Dubreucq S, Mahone M, Granger B.
J Clin Psychopharmacol. 2011 Oct;31(5):671-3. No abstract available.
A self-limiting case of atypical neuroleptic malignant syndrome associated with zotepine.
Hsu WC, Lin ST, Chen CC, Tsang HY, Huang MF.
J Clin Psychopharmacol. 2011 Oct;31(5):667-9. No abstract available.
Late-onset agranulocytosis in a patient treated with clozapine and lamotrigine.
Tourian L, Margolese HC.
J Clin Psychopharmacol. 2011 Oct;31(5):665-7. No abstract available.
Antipsychotic drugs increase adipose stem cell differentiation--implications for treatment with antipsychotic drugs.
Hemmrich K, Kappel BA, Paul NE, Goy D, Luckhaus C, Pallua N, Fehsel K.
J Clin Psychopharmacol. 2011 Oct;31(5):663-5. No abstract available.
Comparing the influence of dopamine D₂ polymorphisms and plasma drug concentrations on the clinical response to risperidone.
Yasui-Furukori N, Tsuchimine S, Saito M, Nakagami T, Sugawara N, Fujii A, Kaneko S.
J Clin Psychopharmacol. 2011 Oct;31(5):633-7.
Superior intellectual ability in schizophrenia: neuropsychological characteristics.
MacCabe JH, Brébion G, Reichenberg A, Ganguly T, McKenna PJ, Murray RM, David AS.
Neuropsychology. 2012 Mar;26(2):181-90. Epub 2011 Dec 26.
Possible influence of CREB1, CREBBP and CREM variants on diagnosis and treatment outcome in patients with schizophrenia.
Crisafulli C, Chiesa A, Han C, Lee SJ, Shim DS, Balzarro B, Andrisano C, Sidoti A, Patkar AA, Pae CU, Serretti A.
Neurosci Lett. 2012 Feb 2;508(1):37-41. Epub 2011 Dec 17.
The efficacy of supported employment for middle-aged and older people with schizophrenia.
Twamley EW, Vella L, Burton CZ, Becker DR, Bell MD, Jeste DV.
Schizophr Res. 2012 Mar;135(1-3):100-4. Epub 2011 Dec 22.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on